Compounds > 2,3-dinor-thromboxane b2

2,3-dinor-thromboxane b2 and Sclerosis, Systemic

2,3-dinor-thromboxane b2 has been researched along with Sclerosis, Systemic in 1 studies

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fitzgerald, GA; Reilly, IA; Roy, L1

Other Studies

1 other study(ies) available for 2,3-dinor-thromboxane b2 and Sclerosis, Systemic

ArticleYear
Biosynthesis of thromboxane in patients with systemic sclerosis and Raynaud's phenomenon.
    British medical journal (Clinical research ed.), 1986, Apr-19, Volume: 292, Issue:6527

    Topics: 6-Ketoprostaglandin F1 alpha; Adult; Cold Temperature; Female; Humans; Male; Middle Aged; Raynaud Disease; Scleroderma, Systemic; Thromboxane A2; Thromboxane B2

1986